Dilatory responses to estrogenic compounds in small femoral arteries of male and female estrogen receptor-β knockout mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 290, Issue 2, 2006, Pages

  Cruz, Maria Natalia ^a   Douglas, Gillian ^b   Gustafsson, Jan Åke ^a   Poston, Lucilla ^b   Kublickiene, Karolina ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Estrogen receptor knockout mice; Femoral arteries; Nitric oxide; Propyl 1H pyrazole 1,3,5 triy trisphenol; Vasodilation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENOL DERIVATIVE; PROPIONITRILE; 1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYL 1H PYRAZOLE; 1,3,5-TRIS(4-HYDROXYPHENYL)-4-PROPYL-1H-PYRAZOLE; 2,3 BIS(4 HYDROXYPHENYL) PROPIONITRILE; 2,3-BIS(4-HYDROXYPHENYL)-PROPIONITRILE; ENZYME INHIBITOR; ESTROGEN; NITRILE; PYRAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY DIAMETER; ARTICLE; BODY WATER; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG STRUCTURE; FEMALE; FEMORAL ARTERY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASOCONSTRICTION; VASODILATATION; WILD TYPE; ANIMAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG POTENTIATION; MOUSE MUTANT; OSMOLARITY; PHYSIOLOGY; SEXUAL DEVELOPMENT;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; FEMORAL ARTERY; MALE; MICE; MICE, KNOCKOUT; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRILES; OSMOLAR CONCENTRATION; PHENOLS; PYRAZOLES; SEX CHARACTERISTICS; VASODILATION;

EID: 33644870827     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00815.2005     Document Type: Article

References (56)

1. Abou-Mohamed G, Elmarakby A, Carrier GO, Catravas JD, Caldwell RW, and White RE. Estradiol relaxes rat aorta via endothelium-dependent and -independent mechanisms. Pharmacology 69: 20-26, 2003.
2. Al Zubair K, Razak A, Bexis S, and Docherty JR. Relaxations to oestrogen receptor subtype selective agonists in rat and mouse arteries. Eur J Pharmacol 513: 101-108, 2005.
3. Andersson C, Lydrup M, Ferno M, Idvall I, Gustafsson J, and Nilsson B. Immunocytochemical demonstration of oestrogen receptor beta in blood vessels of the female rat. J Endocrinol 169: 241-247, 2001.
4. Barton M, Cremer J, and Mugge A. 17beta-Estradiol acutely improves endothelium-dependent relaxation to bradykinin in isolated human coronary arteries. Eur J Pharmacol 362: 73-76, 1998.
5. Bucci M, Roviezzo F, Cicala C, Pinto A, and Cirino G. 17-[beta]-oestradiol-induced vasorelaxation in vitro is mediated by eNOS through hsp90 and akt/pkb dependent mechanism. Br J Pharmacol 135: 1695-1700, 2002.
6. Chambliss KL and Shaul PW. Estrogen modulation of endothelial nitric oxide synthase. Endocr Rev 23: 665-686, 2002.
7. Chambliss KL, Yuhanna IS, Anderson RGW, Mendelsohn ME, and Shaul PW. ER beta has nongenomic action in caveolae. Mol Endocrinol 16: 938-946, 2002.
8. Chen DB, Bird IM, Zheng J, and Magness RR. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology 145: 113-125, 2004.
9. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, and Shaul PW. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103: 401-406, 1999.
10. Chin-Dusting JPF, Fisher LJ, Lewis TV, Piekarska A, Nestel PJ, and Husband A. The vascular activity of some isoflavone metabolites: implications for a cardioprotective role. Br J Pharmacol 133: 595-605, 2001.
11. Collins P, Rosano GM, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill JG, and Poole-Wilson PA. 17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 92: 24-30, 1995.
12. Florian M, Lu Y, Angle M, and Magder S. Estrogen induced changes in Akt-dependent activation of endothelial nitric oxide synthase and vasodilation. Steroids 69: 637-645, 2004.
13. Freay AD, Curtis SW, Korach KS, and Rubanyi GM. Mechanism of vascular smooth muscle relaxation by estrogen in depolarized rat and mouse aorta: role of nuclear estrogen receptor and Ca2+ uptake. Circ Res 81: 242-248, 1997.
14. Garcia-Martinez MC, Hermenegildo C, Tarin JJ, and Cano A. Phytoestrogens increase the capacity of serum to stimulate prostacyclin release in human endothelial cells. Acta Obstet Gynecol Scand 82: 705-710, 2003.
15. Gunnett CA, Lund DD, McDowell AK, Faraci FM, and Heistad DD. Mechanisms of inducible nitric oxide synthase-mediated vascular dysfunction. Arterioscler Thromb Vasc Biol 01.ATV.0000172626.00296.ba, 2005.
16. Guo X, Razandi M, Pedram A, Kassab G, and Levin ER. Estrogen induces vascular wall dilation: mediation through kinase signaling to nitric oxide and estrogen receptors alpha and beta. J Biol Chem 280: 19704-19710, 2005.
17. Hall JM, Couse JF, and Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276: 36869-36872, 2001.
18. Halpern W and Mulvany MJ. Tension responses to small length changes of vascular smooth muscle cells. J Physiol 265: 21P-23P, 1977.
19. Hodges YK, Tung L, Yan XD, Graham JD, Horwitz KB, and Horwitz LD. Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects. Circulation 101: 1792-1798, 2000.
20. Huang J, Nasr M, Kim Y, and Matthews H. Genistein inhibits protein histidine kinase. J Biol Chem 267: 15511-15515, 1992.
21. Krege JH, Hodgin JB, Couse JF, Enmark E, Warner M, Mahler JF, Sar M, Korach KS, Gustafsson JA, and Smithies O. Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 95: 15677-15682, 1998.
22. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, and Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138: 863-870, 1997.
23. Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, and Gustafsson JA. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139: 4252-4263, 1998.
24. Lamping KG and Nuno DW. Effects of 17β-estradiol on coronary microvascular responses to endothelin-1. Am J Physiol Heart Circ Physiol 271: H1117-H1124, 1996.
25. Levin ER. Cellular functions of the plasma membrane estrogen receptor. Trends Endocrinol Metab 10: 374-377, 1999.
26. Lindberg MK, Moverare S, Skrtic S, Gao H, Dahlman-Wright K, Gustafsson JA, and Ohlsson C. Estrogen receptor (ER)-beta reduces ER alpha-regulated gene transcription, supporting a "Ying Yang" relationship between ER alpha and ER beta in mice. Mol Endocrinol 17: 203-208, 2003.
27. Liu D, Homan LL, and Dillon JS. Genistein acutely stimulates nitric oxide synthesis in vascular endothelial cells by a cyclic AMP dependent mechanism (Abstract). Endocrinology 19: 19, 2004.
28. Lobaton CD, Vay L, Hernandez-Sanmiguel E, Santodomingo J, Moreno A, Montero M, and Alvarez J. Modulation of mitochondrial Ca(2+) uptake by estrogen receptor agonists and antagonists (Abstract). Br J Pharmacol 23: 23, 2005.
29. Lu Q, Pallas DC, Surks HK, Baur WE, Mendelsohn ME, and Karas RH. Striatin assembles a membrane signaling complex necessary for rapid, nongenomic activation of endothelial NO synthase by estrogen receptor (alpha). Proc Natl Acad Sci USA 101: 17126-17131, 2004.
30. Luksha L, Poston L, Gustafsson JÅ, Aghajaznova L, and Kublickiene K. Gender specific abnormalities in adrenergic responses of small femoral arteries from estrogen receptor beta knockout mice. Hypertension 45: 1163-1168, 2005.
31. Matthews J and Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv 3: 281-292, 2003.
32. Mendelsohn ME. Genomic and nongenomic effects of estrogen in the vasculature. Am J Cardiol 90: F3-F4, 2002.
33. Meyers MJ, Sun J, Carlson KE, Marriner GA, Katzenellenbogen BS, and Katzenellenbogen JA. Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 44: 4230-4251, 2001.
34. Mishra SK, Abbot SE, Choudhury Z, Cheng M, Khatab N, Maycock NJR, Zavery A, and Aaronson PI. Endothelium-dependent relaxation of rat aorta and main pulmonary artery by the phytoestrogens genistein and daidzein. Cardiovasc Res 46: 539-546, 2000.
35. Montgomery S, Shaw L, Pantelides N, Taggart M, and Austin C. Acute effects of oestrogen receptor subtype-specific agonists on vascular contractility. Br J Pharmacol 139: 1249-1253, 2003.
36. Naderali EK, Walker AB, Doyle P, and Williams G. Comparable vasorelaxant effects of 17alpha- and 17beta-oestradiol on rat mesenteric resistance arteries: an action independent of the oestrogen receptor. Clin Sci (Lond) 97: 649-655, 1999.
37. Nakajima T, Kitazawa T, Hamada E, Hazama H, Omata M, and Kurachi Y. 17beta-Estradiol inhibits the voltage-dependent L-type Ca2+ currents in aortic smooth muscle cells. Eur J Pharmacol 294: 625-635, 1995.
38. Nechmad A, Merin G, Schwalb H, Shimon DV, Borman JB, Milgalter E, and Mosseri M. Estrogen induces nitric oxide-mediated vasodilation of human mammary arteries in vitro. Nitric Oxide 2: 460-466, 1998.
39. Nevala R, Paukku K, Korpela R, and Vapaatalo H. Calcium-sensitive potassium channel inhibitors antagonize genistein- and daidzein-induced arterial relaxation in vitro. Life Sci 69: 1407-1417, 2001.
40. Nilsson BO, Ekblad E, Heine T, and Gustafsson JA. Increased magnitude of relaxation to oestrogen in aorta from oestrogen receptor beta knock-out mice. J Endocrinol 166: R5-R9, 2000.
41. Pettersson K, Delaunay F, and Gustafsson JA. Estrogen receptor beta acts as a dominant regulator of estrogen signaling. Oncogene 19: 4970-4978, 2000.
42. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, and Prossnitz ER. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 1625-1630, 2005.
43. 2β-induced rises in uterine blood flow in ovine pregnancy. Am J Physiol Heart Circ Physiol 281: H422-H431, 2001.
44. Rosenfeld CR, Cox BE, Roy T, and Magness RR. Nitric oxide contributes to estrogen-induced vasodilation of the ovine uterine circulation. J Clin Invest 98: 2158-2166, 1996.
45. Salhab WA, Shaul PW, Cox BE, and Rosenfeld CR. Regulation of types I and III NOS in ovine uterine arteries by daily and acute estrogen exposure. Am J Physiol Heart Circ Physiol 278: H2134-H2142, 2000.
46. Salom JB, Burguete MC, Perez-Asensio FJ, Centeno JM, Torregrosa G, and Alborch E. Acute relaxant effects of 17-[beta]-estradiol through non-genomic mechanisms in rabbit carotid artery. Steroids 67: 339-346, 2002.
47. Santos RL, Abreu GR, Bissoli NS, and Moyses MR. Endothelial mediators of 17 beta-estradiol-induced coronary vasodilation in the isolated rat heart. Braz J Med Biol Res 37: 569-575, 2004.
48. Shaw L, Taggart MJ, and Austin C. Mechanisms of 17 beta-oestradiol induced vasodilatation in isolated pressurized rat small arteries. Br J Pharmacol 129: 555-565, 2000.
49. Simoncini T and Genazzani AR. Non-genomic actions of sex steroid hormones. Eur J Endocrinol 148: 281-292, 2003.
50. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, and Liao JK. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407: 538-541, 2000.
51. Smolders RG, van der Mooren MJ, Kenemans P, van der Linden PW, Stehouwer CD, and Sipkema P. 17 beta-Estradiol induces a rapid, endothelium-dependent, sex-specific vasodilatation in spontaneous constricted rat arterioles. Am J Obstet Gynecol 187: 375-381, 2002.
52. Stauffer SR, Coletta CJ, Tedesco R, Nishiguchi G, Carlson K, Sun J, Katzenellenbogen BS, and Katzenellenbogen JA. Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem 43: 4934-4947, 2000.
53. Taylor AH and Al-Azzawi F. Immunolocalisation of oestrogen receptor beta in human tissues. J Mol Endocrinol 24: 145-155, 2000.
54. Truss M and Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev 14: 459-479, 1993.
55. Van Buren GA, Yang DS, and Clark KE. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 167: 828-833, 1992.
56. Walker HA, Dean TS, Sanders TAB, Jackson G, Ritter JM, and Chowienczyk PJ. The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17beta-estradiol. Circulation 103: 258-262, 2001.